Verification of a blood based targeted proteomics signature for malignant pleural mesothelioma

BACKGROUND: We have verified a mass spectrometry (MS) based targeted proteomics signature for the detection of malignant pleural mesothelioma (MPM) from the blood. METHODS: A seven-peptide biomarker MPM signature by targeted proteomics in serum was identified in a previous independent study. Here, w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Epidemiol Biomarkers Prev
Main Authors: Cerciello, Ferdinando, Choi, Meena, Sinicropi-Yao, Sara L., Lomeo, Katie, Amann, Joseph M., Felley-Bosco, Emanuela, Stahel, Rolf A., Robinson, Bruce WS, Creaney, Jenette, Pass, Harvey I., Vitek, Olga, Carbone, David P.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541795/
https://ncbi.nlm.nih.gov/pubmed/32732250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-20-0543
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki